Researchers at WashU Medicine have received a $12 million grant from the National Institute of Allergy and Infectious Diseases to identify the factors that are responsible for long-lasting immunity against disease.
Tag: COVID-19 Vaccine
Vaccinologists Keith Klugman and Shabir Madhi awarded Sabin’s Prestigious Gold Medal
The Sabin Vaccine Institute presented the Albert B. Sabin Gold Medal to physician-researchers Keith Klugman and Shabir Madhi.
Four years later, what do we know about COVID-19?
Four years ago, a brand new virus turned the world upside down. Today, we know more and can do more about the coronavirus called SARS-CoV2, and the disease called COVID-19, than ever before. A summary of the latest knowledge and guidance.
Vaccines: A few minutes now could spare you misery later
A guide to vaccines that adults – especially older adults and those with underlying health issues – should get to avoid serious illness this fall and winter, and beyond.
Free At-Home COVID Tests and Paxlovid
David Winter, MD, at Baylor Scott & White Health, answers the most common patient questions and reacts to the latest medical research. Are COVID cases starting to go down? (SOT@ :14, TRT :49) How reliable are at-home COVID tests? Can…
Study suggests longer time between COVID-19 vaccines more effective for some
A recent Houston Methodist study may offer some guidance on when certain populations should get their next booster. A research team of computational medicine and data scientists from the Houston Methodist Research Institute predicted the immune response to COVID-19 vaccines with a math model they developed, and also found that current CDC dosing intervals may require customization to protect all individuals alike.
COVID-19 vaccine’s effectiveness diminishes with age, research shows
The Pfizer-BioNTech COVID-19 vaccine limits transmission, hospitalization, and death from COVID-19 even among patients infected by variants of the virus, but the effectiveness of antibodies it generates diminishes as patients get older, according to a study by UT Southwestern researchers.
Third Dose of COVID-19 Vaccine Offers Needed Boost in Protection for Cirrhosis Patients
New research led by researchers at the University of Miami Miller School of Medicine and published in the Journal of Hepatology, suggests that getting a third dose of the COVID-19 mRNA vaccine could overcome the decreased vaccine respons in cirrhosis patients and offer strong protection against the virus, severe illness, and death from COVID-19.
No Significant Increase in Guillain-Barré Syndrome After COVID-19 Vaccination, Researchers Find
There is no evidence that the COVID-19 vaccination increases the incidence of Guillain-Barré syndrome, a rare neurological disorder in which the body’s immune system attacks the nerves, according to a Rutgers-led study.
NCCN Updates Recommendations for COVID-19 Vaccination with Information on Bivalent Vaccines, Children with Cancer, and Other Developments
National Comprehensive Cancer Network Advisory Committee on COVID-19 Vaccination and Pre-exposure Prophylaxis details clarified expert consensus to help guide providers on latest data and information, available at NCCN.org/covid-19.
Study: Slogans protesting federal COVID-19 vaccine mandate displayed three themes
When the Biden administration announced COVID-19 vaccine mandates on Nov. 4 for businesses with 100 or more employees, protests erupted in cities across the U.S.
Myocarditis risk significantly higher after COVID-19 infection vs. after a COVID-19 vaccine
In a detailed analysis of nearly 43 million people, ages 13 and older, who received at least one dose of a COVID-19 vaccine in England, the risk of myocarditis in unvaccinated individuals after COVID-19 infection was at least 11 times higher compared to people who developed myocarditis after receiving a COVID-19 vaccine or booster dose between December 1, 2020 and December 15, 2021, according to new research published today in the American Heart Association’s flagship, peer-reviewed journal Circulation.
Q&A: Advice for a Healthy, Stress-Free Return to School
For the past two-plus years, the COVID-19 pandemic has disrupted children’s education and frustrated parents. Today, with the back-to-school season in full swing, Suzanne Silverstein, MA, ART, founding director of Cedars-Sinai Share & Care, and Rose Bisellach, RN, nurse manager in the Providence Cedars-Sinai Tarzana Medical Center Emergency Room, give their best advice for starting a successful school year.
Most older adults ready to roll up sleeves this fall for updated COVID-19 boosters, U-M poll shows
A new poll shows that 61% of people over 50 who have already gotten at least one dose of COVID-19 vaccine are very likely to roll up their sleeves this fall to get an updated booster shot once they become available.
That percentage might increase if health care providers specifically recommend the updated vaccine to their patients, the poll suggests.
Scientists develop effective intranasal mumps-based COVID-19 vaccine candidate
New research has advanced COVID-19 vaccine work in several ways: using a modified live attenuated mumps virus for delivery, showing that a more stable coronavirus spike protein stimulates a stronger immune response, and suggesting a dose up the nose has an advantage over a shot.
The Medical Minute: Questions answered about COVID vaccines for babies, toddlers
For the last – and littlest – segment of the population yet to receive it, the COVID-19 vaccine is federally approved and available for all people 6 months of age and older. A Penn State Health pediatric infectious disease physician explains why it’s safe and answers questions.
COVID-19 vaccination appears to be safe for patients treated for hypothyroidism
Inactivated and mRNA COVID-19 vaccines appear to be safe for patients treated for hypothyroidism,
according to a new study being presented at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga. The study found these vaccines do not cause significant fluctuations in thyroid function and are not associated with increased risks of emergency department visits or unscheduled hospitalizations.
COVID-19 vaccine incentives get mixed reception from young people
Offering teens and young adults a chance at a college scholarship, cash, discounts or just some free food might help move the needle on COVID-19 vaccination rates, a new study suggests. In all, 82% of people between the ages of 14 and 24 have a positive attitude toward prizes, raffles, giveaways, and other incentives designed to increase vaccination. But a sizable minority of young people have their doubts about whether such vaccine incentives will work or are ethical.
International study reveals factors contributing to COVID-19 vaccine hesitancy among healthcare providers
A new 23-country study by a multidisciplinary team of researchers in the journal Vaccine, published by Elsevier, sheds light on the factors that contribute to COVID-19 vaccine hesitancy among healthcare providers.
Nearly 700,000 US hospitalizations and 110,000 deaths prevented from the Pfizer-BioNTech COVID-19 vaccine, national study finds
The profound health and economic impact of the Pfizer-BioNTech vaccine during its first year of rollout in the US is described in detail in a new study in the peer-reviewed Journal of Medical Economics.
The US reaches 1 Million Deaths from COVID-19: GW Experts Available to Comment
The United States has reached 1 million reported deaths from COVID-19 and that number is likely an undercount, according to the Centers for Disease Control and Prevention. The George Washington University has a number of experts to comment on the…
COVID-19 vaccine elicits weak antibody response in people taking immunosuppressant
People taking TNF inhibitors, a kind of immunosuppressive drug used to treat rheumatoid arthritis and other autoimmune conditions, produced a weaker and shorter-lived antibody response after two doses of Pfizer’s COVID-19 vaccine, according to a study from Washington University School of Medicine in St. Louis. A third vaccine dose drove antibody levels back up, indicating that this additional dose may provide protection as the virus’s delta variant continues to spread.
Flu Season Underway Amid Ongoing COVID-19 Pandemic
For the second straight year, flu season is emerging against the backdrop of the COVID-19 pandemic. While the number of flu cases was relatively low last year, experts at Johns Hopkins Medicine say that this year, it could be much higher.
New COVID vaccine design is easier to manufacture, doesn’t need cold storage
Currently available COVID vaccines require cold storage and sophisticated manufacturing capacity, which makes it difficult to produce and distribute them widely, especially in less developed countries.
Which older adults are getting flu shots and COVID boosters? Poll shows variation
With two viruses threatening to make older adults sick this winter, a new poll shows most people over 50 have gotten protected by vaccines against both influenza and coronavirus, or plan to. And a majority of those who have gotten the COVID-19 vaccine plan to get an additional dose. But the poll also reveals major differences in vaccine attitudes between older adults, including those of different political leanings.
COVID-19 Vaccine Gets Strong Response in Some With Weak Immunity
Researchers at Cedars-Sinai found that patients with inflammatory bowel disease (IBD)─whose treatment can weaken the immune system─produced a strong antibody response to COVID-19 vaccination. The study findings have been published in the Annals of Internal Medicine.
Together by St. Jude Teaches Children about the COVID-19 Vaccines in New Coloring Book
Following FDA authorization of the COVID-19 vaccine for 5- to 11-year-olds, Together by St. Jude releases a free coloring book that educates children on COVID-19 vaccines.
NYU Langone Presentations at American College of Rheumatology Convergence 2021 to Address Vaccine Efficacy and High-risk Pregnancy
NYU Langone rheumatologists are presenting their discoveries at the annual American College of Rheumatology conference, November 1 to November 9. The conference will be held virtually.
FDA authorization of COVID-19 vaccine for kids 5 to 11: IU experts available to comment
Following a daylong meeting Oct. 26, the FDA authorized Pfizer’s COVID-19 vaccine for use in children ages 5 to 11. This was the first in a series of meetings to make this vaccine available to younger children. Next, the Advisory…
COVID-19 vaccines and men’s reproductive health
UAB’s Adam Baumgarten, M.D., shares more on the safety of the COVID-19 vaccine for men.
Healthcare worker vaccine mandate may jumpstart local efforts
Employees at hospitals and long-term care facilities in New York are mandated to get the first dose of the COVID-19 vaccine by Sept. 27, a requirement that has resulted in dozens of staff members quitting their jobs. Adam Seth Litwin, an…
Pregnant Women Who Receive COVID-19 Vaccination Pass Protection from the Virus to Their Newborns
Women who receive COVID-19 mRNA vaccines during pregnancy pass high levels of antibodies to their babies, a new NYU Langone study finds.
Rutgers Pediatric Clinical Trial Experts, Parents Available to Discuss Pfizer’s Vaccine for Children
Rutgers researchers conducting the Pfizer COVID-19 pediatric vaccine clinical trial and parents whose children are participating are available to discuss the recent news of the vaccine prompting a strong immune response in young children.
Patients with Multiple Sclerosis Show Robust T-Cell Responses to mRNA COVID-19 Vaccines
New research shows that Multiple Sclerosis (MS) patients undergoing anti-CD20 (aCD20) treatment – which depletes the B cells that contribute to the MS attacks – are able to mount robust T-cell responses to the mRNA COVID-19 vaccines, despite having a muted antibody response to the vaccines.
The Lancet: Scientific evidence to date on COVID-19 vaccine efficacy does not support boosters for general population, expert review concludes
An expert review by an international group of scientists, including some at the WHO and FDA, concludes that, even for the delta variant, vaccine efficacy against severe COVID is so high that booster doses for the general population are not appropriate at this stage in the pandemic.
Majority of older adults say health care workers should have to get COVID-19 vaccine
Many unvaccinated health care workers will soon be subject to a federal vaccine requirement announced by President Biden. A new poll shows most older adults support a vaccination mandate for doctors, nurses and others.
Lasting Immunity and Protection from New Single-Shot, Room-Temperature Stable COVID-19 Vaccine
Gene-based, single-dose AAVCOVID vaccine shown to offer disease protection in challenge study, and to elicit year-long immune response, according to new paper in Cell Host & Microbe.
“Automated Vaccine Filling Machine”, An Innovation from Chulalongkorn University, Helps Boost the Number of Vaccinations by 20 Percent, and Reduce the Workload of Medical Personnel
The Faculty of Engineering, Chulalongkorn University has developed an automated vaccine filling machine that can fill AstraZeneca vaccine into syringes with precision, speed, and safety, helping to increase the number of vaccinated people by 20 percent. The prototype is now operating at Chula Vaccination Center and more machines are planned to be built to support frontline medical personnel in many vaccination centers soon.
These fridge-free COVID-19 vaccines are grown in plants and bacteria
Nanoengineers at the University of California San Diego have developed COVID-19 vaccine candidates that can take the heat. Their key ingredients? Viruses from plants or bacteria.
Mount Sinai Cardiologist Leads Effort to Outline Guidance for Management of Heart Failure Patients During COVID-19 Pandemic
New scientific statement aims to establish more streamlined care to improve outcomes in this high-risk group
COVID-19 mRNA Vaccine that Uses Fundamental Penn Technology Receives FDA Approval
PHILADELPHIA – The U.S. Food and Drug Administration (FDA) has given the first full approval to a COVID-19 mRNA vaccine, which uses modified mRNA technology invented and developed by scientists in the Perelman School of Medicine at the University of Pennsylvania, whose years of research in mRNA science laid a critical piece of the foundation for the largest global vaccination campaign in history.
Early COVID-19 vaccine campaign in US prevented 140,000 deaths
The early COVID-19 vaccination campaign in the U.S. prevented nearly 140,000 deaths and 3 million cases of COVID-19 by the second week of May, according to a new study.
Cancer Guidelines Organization Supports Mandatory COVID-19 Vaccination for Health Workers
National Comprehensive Cancer Network (NCCN) COVID-19 Vaccination Advisory Committee calls for healthcare workforce vaccine requirements to assure healthcare community is doing all it can to prevent exposure to COVID-19.
Nearly 140,000 U.S. deaths prevented by early COVID-19 vaccinations
A new study by Indiana University and RAND Corp. researchers assessed the impact of COVID-19 vaccination and found that 139,393 deaths were prevented during the first five months of vaccination efforts in the United States.
Mount Sinai Mandates COVID-19 Vaccination for All Faculty and Staff
Mount Sinai Health System today announced that all faculty and staff will be required to get the first shot of the vaccine by September 13.
Mount Sinai Mandates COVID-19 Vaccination for All Faculty and Staff
Mount Sinai Health System today announced that all faculty and staff will be required to get the first shot of the vaccine by September 13.
Ask a Scientist: Should I consider getting vaccinated against COVID-19?
Ask a Scientist: Should I consider getting vaccinated against COVID-19?
Should COVID-19 Vaccination Be Mandatory for Health and Care Staff?
Italy, France, and Greece have made covid-19 vaccination mandatory for healthcare workers, and England is making it compulsory for care home workers and consulting on whether to extend this to healthcare workers and other social care staff.
Spreading ‘Doses of Hope’ as COVID-19 Cases Rise
In an emotional new series of videos, Black medical professionals plead for viewers to get a COVID-19 vaccine.
Support for Government Mandates High and Increasing Over Time, Survey Finds
As the coronavirus Delta variant surges throughout the country and mask and vaccine mandates are being considered, a new national survey finds that almost 20 percent of Americans say it is unlikely that they will get the COVID-19 vaccine.